A formal collaboration to advance a common internal pipeline of drug development projects Barcelona, 16 March 2022 – Today we announce the start of the formal collaboration between Acellera and…
Read More
Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet clinical…
In less than 12 months, the collaboration between Chemotargets and Galyan Bio yields a scaffold for first-in-class clinical candidates in difficult area of neurodegenerative disease. Chemotargets employed its proprietary AI-driven…
The collaboration aims to enhance CDER’s safety assessments of human pharmaceuticals, supporting the FDA’s mission of protecting public health. Barcelona / Washington D.C., USA: The Food and Drug Administration’s Center…
